Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer

Sudhakar, 2009, J. Cancer Sci. Ther., 1, 1, 10.4172/1948-5956.100000e2

Nagai, 2017, J. Thorac. Dis., 9, 448, 10.21037/jtd.2017.02.75

Wu, 2016, Mol. Cell. Oncol., 3

Wu, 2016, Nature, 529, 43, 10.1038/nature16166

Mukhtar, 2014, Mol. Cancer Ther., 13, 275, 10.1158/1535-7163.MCT-13-0791

Dumontet, 2010, Nat. Rev. Drug Discov., 9, 790, 10.1038/nrd3253

Gotwals, 2017, Nat. Rev. Cancer, 17, 286, 10.1038/nrc.2017.17

Kakde, 2011, J. Appl. Pharm. Sci., 1, 1

Chidambaram, 2011, J. Pharm. Pharm. Sci., 14, 67, 10.18433/J30C7D

Wang, 2006, Curr. Cancer Ther. Rev., 2, 271, 10.2174/157339406777934717

Taylor, 2017, Sci. Transl. Med., 9, 10.1126/scitranslmed.aam8060

Frenkel, 2013, Oncologist, 18, 634, 10.1634/theoncologist.2012-0436

Sutradhar, 2014, ISRN Nanotechnol., 2014, 10.1155/2014/939378

Tekade, 2017, Chapter 1 - nanotechnology for the development of nanomedicine A2 - Mishra, Vijay, 3

van Vlerken, 2008, Mol. Pharm., 5, 516, 10.1021/mp800030k

Danhier, 2010, J. Control. Release, 148, 135, 10.1016/j.jconrel.2010.08.027

Huang, 2010, ACS Nano, 4, 5887, 10.1021/nn102055s

E.A. Sykes, J. Chen, G. Zheng, W.C. Chan, 8 (2014) 5696–706.

Wakaskar, 2017, Int. J. Drug Dev. Res., 9, 3

Balkwill, 2012, J. Cell Sci., 125, 5591, 10.1242/jcs.116392

Whiteside, 2008, Oncogene, 27, 5904, 10.1038/onc.2008.271

Chen, 2015, BMC Med., 13, 45, 10.1186/s12916-015-0278-7

Mbeunkui, 2009, Cancer Chemother. Pharmacol., 63, 571, 10.1007/s00280-008-0881-9

Ruoslahti, 2002, Nat. Rev. Cancer, 2, 83, 10.1038/nrc724

Siemann, 2011, Cancer Treat. Rev., 37, 63, 10.1016/j.ctrv.2010.05.001

Byrne, 2008, Adv. Drug Deliv. Rev., 60, 1615, 10.1016/j.addr.2008.08.005

Maeda, 1986, 353

Greish, 2007, J. Drug Target., 15, 457, 10.1080/10611860701539584

Matsumura, 1986, Cancer Res., 46, 6387

Maeda, 2012, Proc. Jpn. Acad. Ser. B, 88, 53, 10.2183/pjab.88.53

Sykes, 2016, Proc. Natl. Acad. Sci., 113, E1142, 10.1073/pnas.1521265113

Raeesi, 2016, Nanoscale, 8, 12524, 10.1039/C5NR08463F

Blanco, 2015, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330

Wang, 2014, Oncol. Rep., 32, 1709, 10.3892/or.2014.3366

Lu, 2010, J. Cell. Biochem., 110, 141, 10.1002/jcb.22580

Yu, 2014, Biochem. Pharmacol., 87, 243, 10.1016/j.bcp.2013.10.016

Goel, 2013, Nat. Rev. Cancer, 13, 871, 10.1038/nrc3627

Roberts, 2013, Prostate Cancer, 2013, 418340, 10.1155/2013/418340

Terman, 2001, Einstein Quart. J. Biol. Med., 18, 59

Dai, 2004, Cancer Res., 64, 994, 10.1158/0008-5472.CAN-03-1382

Nakanishi, 2013, 123

Greenhough, 2009, Carcinogenesis, 30, 377, 10.1093/carcin/bgp014

Howe, 2007, Breast Cancer Res., 9, 210, 10.1186/bcr1678

Thun, 1991, N. Engl. J. Med., 325, 1593, 10.1056/NEJM199112053252301

Szabó, 2007, Nat. Rev. Drug Discov., 6, 662, 10.1038/nrd2222

Iyer, 2006, Drug Discov. Today, 11, 812, 10.1016/j.drudis.2006.07.005

Wu, 2001, Cancer Sci., 92, 439

Wang, 2008, Acta Pharmacol. Sin., 29, 1275, 10.1111/j.1745-7254.2008.00889.x

Yan, 2006, Cancer Res., 66, 11565, 10.1158/0008-5472.CAN-06-2540

Choudhari, 2013, World J. Surg. Oncol., 11, 118, 10.1186/1477-7819-11-118

Vahora, 2016, J. Cancer Prev., 21, 1, 10.15430/JCP.2016.21.1.1

Huerta, 2015, Futur. Sci. OA, 1, FSO44, 10.4155/fso.15.44

Burke, 2013, Carcinogenesis, 34, 503, 10.1093/carcin/bgt034

Chau, 2015, J. Biomed. Sci., 22, 22, 10.1186/s12929-015-0128-0

Otterbein, 2011, Proc. Natl. Acad. Sci., 108, 14491, 10.1073/pnas.1102295108

Tamarkin, 2017, Ther. Deliv., 8, 363, 10.4155/tde-2016-0095

Fang, 2012, Cancer Sci., 103, 535, 10.1111/j.1349-7006.2011.02178.x

Ishihara, 2001, Jpn. J. Pharmacol., 87, 318, 10.1254/jjp.87.318

Naidu, 2014, Afr. Health Sci., 14, 657, 10.4314/ahs.v14i3.22

Yu, 2013, Int. J. Mol. Sci., 14, 13329, 10.3390/ijms140713329

Nakamura, 2006, Clin. Cancer Res., 12, 1201, 10.1158/1078-0432.CCR-05-1269

Waters, 2013, J. Pathol., 230, 241, 10.1002/path.4188

van Etten, 2003, Br. J. Cancer, 88, 314, 10.1038/sj.bjc.6600707

De Wilt, 2000, Br. J. Cancer, 82, 1000, 10.1054/bjoc.1999.1032

Shenoi, 2013, Mol. Pharm., 10, 1683, 10.1021/mp300505w

Tanaka, 2003, J. Drug Target., 11, 45, 10.1080/1061186031000086072

Nel, 2017, ACS Publ., 11, 9567

Sousa, 2017, Sci. Rep., 7, 3736, 10.1038/s41598-017-03959-4

Maeda, 2013, Adv. Drug Deliv. Rev., 65, 71, 10.1016/j.addr.2012.10.002

Greish, 2010, Cancer Nanotechnol. Meth. Protocol., 624, 25, 10.1007/978-1-60761-609-2_3

Suzuki, 1981, J. Natl. Cancer Inst., 67, 663

Zhen, 2014, ACS Nano, 8, 6004, 10.1021/nn501134q

Seki, 2009, Cancer Sci., 100, 2426, 10.1111/j.1349-7006.2009.01323.x

Maeda, 2003, Int. Immunopharmacol., 3, 319, 10.1016/S1567-5769(02)00271-0

Yasuda, 2006, J. Clin. Oncol., 24, 688, 10.1200/JCO.2005.04.0436

Siemens, 2009, Urology, 74, 878, 10.1016/j.urology.2009.03.004

Horvath, 2013, Med. Hypotheses, 80, 684, 10.1016/j.mehy.2013.01.027

Maeda, 2015, Adv. Drug Deliv. Rev., 91, 3, 10.1016/j.addr.2015.01.002

Nagamitsu, 2009, Jpn. J. Clin. Oncol., 39, 756, 10.1093/jjco/hyp074

Shibata, 1989, Cancer, 64, 1586, 10.1002/1097-0142(19891015)64:8<1586::AID-CNCR2820640805>3.0.CO;2-E

Elyamany, 2014, Clin. Med. Insights Oncol., 8, 129, 10.4137/CMO.S18991

Barbosa, 2014, Clin. Med. Insights Oncol., 8, 49, 10.4137/CMO.S13386

Hammond, 2003, Investig. New Drugs, 21, 309, 10.1023/A:1025468611547

Papathanassiou, 2009, Crit. Rev. Oncol. Hematol., 72, 239, 10.1016/j.critrevonc.2008.10.006

Oriuchi, 2006, Cancer Sci., 97, 1291, 10.1111/j.1349-7006.2006.00341.x

Czernin, 2013, Curr. Radiol. Rep., 1, 177, 10.1007/s40134-013-0016-x

Van Dort, 2008, Curr. Comput. Aided Drug Des., 4, 46, 10.2174/157340908783769265

Hernando, 2010, Clin. Transl. Oncol., 12, 606, 10.1007/s12094-010-0565-x

Guimaraes, 2014, Radiol. Bras., 47, 101, 10.1590/S0100-39842014000200013

Rosenkrantz, 2016, Am. J. Roentgenol., 206, 162, 10.2214/AJR.15.14968

Herranz, 2012, J. Oncol., 2012, 863747, 10.1155/2012/863747

Hadjipanayis, 2011, 38, 109

Herzog, 2012, Radiology, 263, 461, 10.1148/radiol.11111646

Weissleder, 2006, Science, 312, 1168, 10.1126/science.1125949

Ardeshirpour, 2011, Technol. Cancer Res. Treat., 10, 549, 10.1177/153303461101000605

Shin, 2010, Future Oncol., 6, 1143, 10.2217/fon.10.79

Blažková, 2015, J. Metallomics Nanocryst. Mater., 2, 48

Steichen, 2013, Eur. J. Pharm. Sci., 48, 416, 10.1016/j.ejps.2012.12.006

Nakamura, 2016, Chem. Pharm. Bull. (Tokyo), 64, 512, 10.1248/cpb.c15-00992

Li, 2014, Chem. Mater., 26, 6418, 10.1021/cm503304p

Bulbake, 2017, Pharmaceutics, 9, 12, 10.3390/pharmaceutics9020012

Zhang, 2016, OncoTargets and therapy, 9, 3001, 10.2147/OTT.S105587

Oerlemans, 2010, Pharm. Res., 27, 2569, 10.1007/s11095-010-0233-4

Davis, 2008, Nat. Rev. Drug Discov., 7, 771, 10.1038/nrd2614

Chang, 2012, Int. J. Nanomedicine, 7, 49

Maheshwari, 2015, Sci. Adv. Mater., 7, 1163, 10.1166/sam.2015.2245

Maheshwari, 2012, Saudi Pharm. J., 20, 161, 10.1016/j.jsps.2011.10.001

Bhowmik, 2018, Cancer Chemother. Pharmacol., 82, 521, 10.1007/s00280-018-3643-3

Huwyler, 2008, Int. J. Nanomedicine, 3, 21, 10.2147/IJN.S1253

Akbarzadeh, 2013, Nanoscale Res. Lett., 8, 102, 10.1186/1556-276X-8-102

Li, 2015, Asian J. Pharm. Sci., 10, 81, 10.1016/j.ajps.2014.09.004

Xing, 2016, Theranostics, 6, 1336, 10.7150/thno.15464

Khokhlova, 2015, Ther. Adv. Gastroenterol., 8, 384, 10.1177/1756283X15592584

C.M. Dawidczyk, Johns Hopkins University, 2015.

Yu, 2018, Adv. Mater., 30, 1704934, 10.1002/adma.201704934

Hansen, 2015, ACS Nano, 9, 6985, 10.1021/acsnano.5b01324

Ibsen, 2013, Drug Des. Devel. Ther., 7, 375, 10.2147/DDDT.S31564

Cosgrove, 2015, Cancer Imaging, 15, O17, 10.1186/1470-7330-15-S1-O17

Kotopoulis, 2013, Med. Phys., 40, 10.1118/1.4808149

Dimcevski, 2016, J. Control. Release, 243, 172, 10.1016/j.jconrel.2016.10.007

Nofiele, 2013, Technol. Cancer Res. Treat., 12, 53, 10.7785/tcrt.2012.500253

Liu, 2017, ACS Nano, 11, 1509, 10.1021/acsnano.6b06815

Ahmed, 2013, Biomed. Res. Int., 2013, 281230

Zhang, 2006, Cancer Genomics Proteomics, 3, 147

Thomas, 2013, Int. J. Mol. Sci., 14, 15910, 10.3390/ijms140815910

Bañobre-López, 2013, Rep. Pract. Oncol. Radiother., 18, 397, 10.1016/j.rpor.2013.09.011

Brigger, 2002, Adv. Drug Deliv. Rev., 54, 631, 10.1016/S0169-409X(02)00044-3

Miller, 2015, Sci. Transl. Med., 7, 314ra183, 10.1126/scitranslmed.aac6522

Kim, 2017, J. Am. Chem. Soc., 139, 10992, 10.1021/jacs.7b05559

Tekade, 2017, 4 - biopolymer-based nanocomposites for transdermal drug delivery, 81

Prabhu, 2015, Int. J. Nanomedicine, 10, 1001

Masood, 2016, Mater. Sci. Eng. C, 60, 569, 10.1016/j.msec.2015.11.067

Wen, 2017, Polymers, 9, 213, 10.3390/polym9060213

Johnstone, 2013, ACS Nano, 7, 5675, 10.1021/nn401905g

Husseini, 2008, J. Nanosci. Nanotechnol., 8, 2205, 10.1166/jnn.2008.225

Blanco, 2009, Exp. Biol. Med., 234, 123, 10.3181/0808-MR-250

Cho, 2011, ACS Nano, 5, 8721, 10.1021/nn202676u

Soni, 2017, Curr. Pharm. Des., 23, 3084, 10.2174/1381612823666170329150201

Tekade, 2008, Chem. Rev., 109, 49, 10.1021/cr068212n

Palmerston Mendes, 2017, Molecules, 22, 1401, 10.3390/molecules22091401

Boas, 2006, J. Mater. Chem., 16, 3785, 10.1039/b611813p

Tambe, 2017, Curr. Pharm. Des., 23, 2952, 10.2174/1381612823666170314104619

Barbara, 2001, Acta Biochim. Pol., 48, 199, 10.18388/abp.2001_5127

Baig, 2015, Int. J. Adv. Pharm. Biol. Chem, 2015, 44

Kesharwani, 2015, Drug Discov. Today, 20, 536, 10.1016/j.drudis.2014.12.012

Duncan, 2005, Adv. Drug Deliv. Rev., 57, 2215, 10.1016/j.addr.2005.09.019

Wong, 2015, PLoS One, 10

Charrois, 2004, Biochim. Biophys. Acta Biomembr., 1663, 167, 10.1016/j.bbamem.2004.03.006

Petschauer, 2015, Nanomedicine, 10, 447, 10.2217/nnm.14.179

Tong, 2016, Theranostics, 6, 2039, 10.7150/thno.17098

Kobayashi, 2014, Theranostics, 4, 81, 10.7150/thno.7193

Singh, 2009, Exp. Mol. Pathol., 86, 215, 10.1016/j.yexmp.2008.12.004

Li, 2008, Mol. Pharm., 5, 496, 10.1021/mp800049w

Charrois, 2003, Biochim. Biophys. Acta Biomembr., 1609, 102, 10.1016/S0005-2736(02)00661-2

Desimone, 2012, 1, 90

Xu, 2013, Angew. Chem. Int. Ed., 52, 6580, 10.1002/anie.201209145

Natfji, 2017, J. Pharm. Sci., 106, 3179, 10.1016/j.xphs.2017.06.019

Anderson, 2003, Br. J. Cancer, 89, 262, 10.1038/sj.bjc.6601105

Heneweer, 2011, J. Nucl. Med., 52, 625, 10.2967/jnumed.110.083998

Padera, 2016, Annu. Rev. Biomed. Eng., 18, 125, 10.1146/annurev-bioeng-112315-031200

Rahman, 2015, Oncol. Lett., 10, 1233, 10.3892/ol.2015.3486

Ji, 2016, Int. J. Mol. Sci., 18, 51, 10.3390/ijms18010051

Alitalo, 2012, Oncogene, 31, 4499, 10.1038/onc.2011.602

Tammela, 2010, Cell, 140, 460, 10.1016/j.cell.2010.01.045

Shayan, 2006, Carcinogenesis, 27, 1729, 10.1093/carcin/bgl031

Nakamura, 2016, Bioconjug. Chem., 27, 2225, 10.1021/acs.bioconjchem.6b00437

Nandhakumar, 2017, Bull. Fac. Pharm. Cairo Univ., 55, 249, 10.1016/j.bfopcu.2017.06.003

Xie, 2009, Expert Opin. Drug Deliv., 6, 785, 10.1517/17425240903085128

Barua, 2014, Nano Today, 9, 223, 10.1016/j.nantod.2014.04.008

Wong, 2011, Proc. Natl. Acad. Sci., 108, 2426, 10.1073/pnas.1018382108

Baronzio, 2015, Front. Oncol., 5, 165, 10.3389/fonc.2015.00165

Welter, 2013, PLoS One, 8, e70395, 10.1371/journal.pone.0070395

Jain, 2005, Science, 307, 58, 10.1126/science.1104819

Gao, 2017, ACS Appl. Mater. Interfaces, 9, 29457, 10.1021/acsami.7b05119

Azzi, 2013, Front. Oncol., 3, 211, 10.3389/fonc.2013.00211

Dewhirst, 2016, Cancer Res., 76, 3118, 10.1158/0008-5472.CAN-16-1292

Senger, 1986, Cancer Res., 46, 5629

Yin, 2014, JSM Clin. Oncol. Res., 2, 1010

Ma, 2011, Cancer Res., 71, 2675, 10.1158/0008-5472.CAN-10-3242

Clark, 2016, Proc. Natl. Acad. Sci., 113, 3850, 10.1073/pnas.1603018113

Martin, 2007, CHEST J., 131, 290, 10.1378/chest.06-1281

Minchinton, 2006, Nat. Rev. Cancer, 6, 583, 10.1038/nrc1893

Hare, 2017, Adv. Drug Deliv. Rev., 108, 25, 10.1016/j.addr.2016.04.025

Hirschfeld, 2002, Crit. Rev. Oncol. Hematol., 42, 137, 10.1016/S1040-8428(02)00008-2

Ran, 2018, Eur. J. Pharm. Biopharm., 130, 1, 10.1016/j.ejpb.2018.06.017

Liang, 2018, NPG Asia Mater., 10, 761, 10.1038/s41427-018-0066-x

Rosenblum, 2018, Nat. Commun., 9, 1410, 10.1038/s41467-018-03705-y

Muniswamy, 2018, Int. J. Pharm., 555, 77, 10.1016/j.ijpharm.2018.11.035

Jogi, 2018, Nanomedicine, 13, 1187, 10.2217/nnm-2017-0397

Torchilin, 2014, Nat. Rev. Drug Discov., 13, 813, 10.1038/nrd4333

Vigor, 2010, Biomaterials, 31, 1307, 10.1016/j.biomaterials.2009.10.036